SBDR - SOCIETY FOR BIOMEDICAL DIABETES RESEARCH
Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations